These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6872316)

  • 1. Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes.
    Hersey P; Lawrence S; Prendergast D; Bindon C; Benson W; Valk P
    Clin Exp Immunol; 1983 Jun; 52(3):551-60. PubMed ID: 6872316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
    O'Sullivan MM; Walker DM; Williams BD
    Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary disorders associated with Sjögren's syndrome.
    Fairfax AJ; Haslam PL; Pavia D; Sheahan NF; Bateman JR; Agnew JE; Clarke SW; Turner-Warwick M
    Q J Med; 1981; 50(199):279-95. PubMed ID: 7330166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial Sjögren's syndrome, pseudolymphoma and selective C4 deficiency associated with cryoglobulinemia].
    Batlle Fondrodona J; Cordero Sánchez M; Martínez López de Letona J; López Borrasca A
    Rev Clin Esp; 1980 Sep; 158(6):321-5. PubMed ID: 7209029
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune complexes and reticuloendothelial system function in human disease.
    Lawley TJ
    J Invest Dermatol; 1980 May; 74(5):339-43. PubMed ID: 7391607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.
    McGinley E; Martin W; Henderson N; Boulton-Jones JM
    Clin Exp Immunol; 1984 May; 56(2):295-301. PubMed ID: 6587955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HL-A antigen in Sjögren's syndrome.
    Nahir AM; Scharf Y; Gidoni O; Koren L; Zonis S; Barzilai A
    Ann Ophthalmol; 1980 Sep; 12(9):1084-6. PubMed ID: 6985419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance.
    Hamburger MI; Moutsopoulos HM; Lawley TJ; Frank MM
    Ann Intern Med; 1979 Oct; 91(4):534-8. PubMed ID: 484951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
    Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.
    Atkinson JC; Fox PC; Travis WD; Popek E; Katz RW; Balow JE; Pillemer SR
    J Rheumatol; 1989 Sep; 16(9):1205-10. PubMed ID: 2810277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome (Sicca syndrome): current issues.
    Moutsopoulos HM; Chused TM; Mann DL; Klippel JH; Fauci AS; Frank MM; Lawley TJ; Hamburger MI
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):212-26. PubMed ID: 7352730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
    Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
    Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of reticuloendothelial system function in man using receptor-specific probes.
    Hamburger MI
    Neth J Med; 1984; 27(9):359-67. PubMed ID: 6239984
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement genes contribute sex-biased vulnerability in diverse disorders.
    Kamitaki N; Sekar A; Handsaker RE; de Rivera H; Tooley K; Morris DL; Taylor KE; Whelan CW; Tombleson P; Loohuis LMO; ; Boehnke M; Kimberly RP; Kaufman KM; Harley JB; Langefeld CD; Seidman CE; Pato MT; Pato CN; Ophoff RA; Graham RR; Criswell LA; Vyse TJ; McCarroll SA
    Nature; 2020 Jun; 582(7813):577-581. PubMed ID: 32499649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of membranous glomerulonephritis in a patient with rheumatoid arthritis and Sjögren's syndrome.
    Schwartzberg M; Burnstein SL; Calabro JJ; Jacobs JB
    J Rheumatol; 1979; 6(1):65-70. PubMed ID: 439113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in Sjögren's syndrome.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Oct; 5(4):367-74. PubMed ID: 6166090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of circulating immune complexes in Sjögren's syndrome.
    Lawley TJ; Moutsopoulos HM; Katz SI; Theofilopoulos AN; Chused TM; Frank MM
    J Immunol; 1979 Sep; 123(3):1382-7. PubMed ID: 469255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.